[ad_1] Shares of Vaxart Inc. VXRT, -0.71% up 44% in trade before marketing Thursday, after the biotech company announced the results of a phase 2 trial that its oral flu vaccine would …
Read More »The Vaxart stock flies after the optimistic results of an oral flu vaccine trial
